The term 'biomedical imaging' covers activities that involve the use and development of imaging techniques in preclinical and clinical medicine. This includes basic research into new methods for the acquisition of images and their analysis and the application of imaging tools to enable other scientific endeavours.
We specialise in the development and application of advanced image acquisition and processing techniques across a range of imaging modalities; from PET and MRI to histological/microscopy imaging and ultrasound. This technology is applied in the understanding of human and biological systems across a range of disease areas.
We work with partners across the University, with funding from charities, research councils and industry to improve our understanding of tissue and organ function in health and disease.
For more information, see:
Professor Geoff Parker is the Director of the Biomedical Imaging Institute. His main research interests are the development and application of novel magnetic resonance imaging biomarkers in cancer, neuroscience and the lung.
Researchers in Manchester have a long tradition of medical imaging research. One of the first clinical CT machines was installed in Manchester, and the first commercial MR scanner in Europe (from Picker Ltd) was installed in 1983 in the Department of Diagnostic Radiology at the University of Manchester Medical School.
The University currently has substantial investment in imaging equipment for PET and MRI for clinical and preclinical research located on the central University campus and embedded with University Trusts. Continued investment in state-of-the-art imaging equipment is destined to guarantee the reputation of the city as a world-leader in medical imaging research for years to come. For more information, see:
This website will look much better in a web browser that supports web standards, but it is accessible to any browser or Internet device.